Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study.
Jurjen VersluisWael SaberHarrison K TsaiChristopher J GibsonLaura W DillonAsmita MishraJoseph P McGuirkRichard T MaziarzPeter WesterveltPranay S HegdeDevdeep MukherjeeMichael J MartensBrent R LoganMary M HorowitzChristopher S HouriganRyotaro NakamuraCorey S CutlerR Coleman Lindsleynull nullPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
mutation had favorable outcomes when a donor was available.